Wright Medical Group (WMGI) Posts Q4 Loss of $0.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Wright Medical (WMGI) PT Raised to $31 at BMO Capital Following Strong 4Q Results
February 22, 2017 8:59 AM ESTBMO Capital Markets analyst Joanne Wuensch reiterates Outperform rating and raises price target on Wright Medical Group NV (NASDAQ: WMGI) to $31 (from 427), suggesting a positive outlook, as the company reported 2016 fourth quarter revenues and EPS above consensus, offering 2017 guidance above consensus estimates.
Wuensch... More
Jefferies Reiterates Buy on Wright Medical Group (WMGI) Following 4Q
February 22, 2017 7:14 AM ESTJefferies reiterated a Buy rating and $30.00 price target on Wright Medical Group (NASDAQ: WMGI) following the company's 4Q earnings report.
Analyst Raj Denhoy commented, "4Q was positive on numerous fronts: +15% underlying sales growth driven by Shoulders, Biologic, and Ankles; 11.7% EBITDA margins, a new high... More
Needham & Company Maintains Hold Rating on Wright Medical Group (WMGI) Following Strong 4Q16 Results
February 22, 2017 6:26 AM ESTNeedham and & Company analyst Mike Matson reiterates Hold rating on Wright Medical Group NV (NASDAQ: WMGI), as the company delivered 2016 fourth quarter revenue and EBITDA above consensus, while offering 2017 revenue guidance above consensus projections.
Matson comments, "WMGI's 4Q16 revenue and EBITDA beat consensus, and... More
